CASI Pharmaceuticals (CASI) News Today

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

$2.25

+0.01 (+0.45%)

(As of 04/19/2024 ET)

Source

Source	Headline
	Oramed Pharmaceuticals (NASDAQ:ORMP) vs. CASI Pharmaceuticals (NASDAQ:CASI) Financial Contrast americanbankingnews.com - April 20 at 1:28 AM
	CASI Pharmaceuticals updates on Juventas dispute investing.com - April 10 at 3:15 PM
	CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS finance.yahoo.com - April 8 at 9:27 PM
	Recap: CASI Pharmaceuticals Q4 Earnings benzinga.com - March 28 at 1:26 PM
	CASI Stock Earnings: CASI Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 markets.businessinsider.com - March 28 at 1:26 PM
	CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS finance.yahoo.com - March 28 at 8:25 AM
	Aptevo Therapeutics: Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference finanznachrichten.de - March 18 at 9:46 AM
	CASI Apr 2024 2.500 call finance.yahoo.com - March 16 at 5:20 AM
	Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division markets.businessinsider.com - March 11 at 7:49 AM
	Aptevo Therapeutics, Immuron, CASI Pharmaceuticals among healthcare movers msn.com - March 8 at 10:55 AM
	CASI Mar 2024 10.000 call finance.yahoo.com - March 7 at 1:36 PM
	CASI Mar 2024 7.500 put finance.yahoo.com - March 7 at 1:36 PM
	marketbeat.com - March 5 at 3:42 PM
	CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients msn.com - March 5 at 2:26 PM
	marketbeat.com - March 5 at 9:41 AM
	CASI stock rises on positive interim data from early stage trial for its NHL treatment in China msn.com - March 5 at 9:25 AM
	CASI Pharma Shares Soar After Positive Preliminary Trial Data for Cancer Immunotherapy marketwatch.com - March 5 at 9:25 AM
	CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In China prnewswire.com - March 5 at 7:00 AM
	CASI begins dosing lymphoma patients with pralatrexate in China msn.com - February 20 at 12:54 AM
	CASI Pharmaceuticals Reveals Business and Financial Updates Quarter 2024 msn.com - February 18 at 9:54 AM
	CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above 200-Day Moving Average of $4.39 marketbeat.com - February 17 at 3:31 AM
	CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA finance.yahoo.com - February 16 at 10:28 AM
	CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA prnewswire.com - February 16 at 7:00 AM
	Analysts’ Opinions Are Mixed on These Healthcare Stocks: CymaBay Therapeutics (CBAY), G1 Therapeutics (GTHX) and Gritstone Oncology (GRTS) markets.businessinsider.com - February 13 at 10:14 AM
	CASI Pharmaceuticals (NASDAQ:CASI) Share Price Crosses Above Two Hundred Day Moving Average of $4.24 marketbeat.com - February 9 at 3:45 AM
	CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com marketbeat.com - February 9 at 1:21 AM
	CASI Pharmaceuticals (NASDAQ:CASI) Research Coverage Started at StockNews.com marketbeat.com - February 1 at 1:43 AM
	Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer es-us.finanzas.yahoo.com - January 31 at 10:12 AM
	Switch Therapeutics Appoints Charles Allerson, Ph.D., as Chief Technology Officer finance.yahoo.com - January 3 at 7:31 AM
	CASI Pharmaceuticals Stock (NASDAQ:CASI) Dividends: History, Yield and Dates benzinga.com - December 28 at 8:08 PM
	CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Price Is Right But Growth Is Lacking After Shares Rocket 33% finance.yahoo.com - December 18 at 8:30 AM
	CASI Pharmaceuticals Inc CASI morningstar.com - December 16 at 11:54 PM
	HC Wainwright & Co. Maintains Buy Rating for CASI Pharmaceuticals: Here's What You Need To Know markets.businessinsider.com - November 15 at 1:58 PM
	CASI Pharmaceuticals Posts Narrower Loss In Q3 markets.businessinsider.com - November 14 at 10:21 AM
	CASI Pharmaceuticals GAAP EPS of -$0.35, revenue of $8.84M msn.com - November 14 at 10:21 AM
	CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES finance.yahoo.com - November 14 at 10:21 AM
	CASI : Juventas' CNCT 19 Approved In China For R/R B-cell Acute Lymphoblastic Leukemia Treatment markets.businessinsider.com - November 8 at 8:33 AM
	H.C. Wainwright Sticks to Its Buy Rating for CASI Pharmaceuticals (CASI) markets.businessinsider.com - August 14 at 9:43 AM
	CASI Pharmaceuticals, Inc. Q2 Loss Widens markets.businessinsider.com - August 11 at 6:11 PM
	CASI Pharmaceuticals GAAP EPS of -$0.77, revenue of $9.82M msn.com - August 11 at 6:11 PM
	CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES finance.yahoo.com - August 11 at 6:11 PM
	Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Surpass Estimates (Revised) msn.com - August 10 at 5:10 PM
	ProPhase Labs, Inc. (PRPH) Reports Q2 Loss, Lags Revenue Estimates msn.com - August 10 at 11:06 AM
	Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals finance.yahoo.com - August 1 at 7:28 PM
	Cleave Therapeutics Announces Acquisition of Clinical and Preclinical Assets finance.yahoo.com - July 20 at 8:35 AM
	CASI Pharmaceuticals Acquires Global Intellectual Property Rights to Cleave Therapeutics' VCP/P97 Inhibitor CB-5339 finance.yahoo.com - July 20 at 8:35 AM
	Switch Therapeutics Appoints Douglas Fambrough, Ph.D., to Board of Directors finance.yahoo.com - July 10 at 8:11 AM
	CASI - CASI Pharmaceuticals, Inc. finance.yahoo.com - June 28 at 8:27 PM
	We Think CASI Pharmaceuticals (NASDAQ:CASI) Needs To Drive Business Growth Carefully finance.yahoo.com - May 28 at 10:37 AM
	CASI Pharmaceuticals, Inc. Announces First Quarter 2023 Financial Results finanznachrichten.de - May 17 at 8:52 AM

Get CASI Pharmaceuticals News Delivered to You Automatically

Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

CASI Media Mentions By Week

CASI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CASI
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

CASI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CASI Articles
This Week
▼
0

1
▲
CASI Articles
Average Week

Get CASI Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:CASI) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CASI Pharmaceuticals (CASI) News Today

CASI Media Mentions By Week

CASI Media Sentiment

CASI News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info